Full-Time

Senior Business Consultant

R&D

Confirmed live in the last 24 hours

Veeva Systems

Veeva Systems

5,001-10,000 employees

Quality and regulatory software solutions provider

No salary listed

Senior

Company Historically Provides H1B Sponsorship

London, UK

Candidates must be legally authorized to be employed in the EU (for EU locations, incl. Switzerland) and the UK (for UK-based candidates).

Category
Management Consulting
Consulting
Requirements
  • Bachelor's or Master’s degree and excellent academic record
  • 4+ years consulting experience in an established strategic/management consulting organization
  • Experience in Life Sciences
  • Good understanding and deep interest in pharmaceutical R&D, having delivered consulting engagements in one or more of the following areas: Regulatory, Clinical, Quality, Safety
  • Good understanding of the R&D value chain and ideally Veeva’s platforms/solutions and how R&D business consulting offerings can leverage and support these
  • Good understanding of the business capabilities and drivers underpinning digital technology in health and life sciences
  • Proven analytical skills, able to quantitatively and qualitatively assess problems and communicate responses across a range of issues
  • A problem-solving mindset: anticipating issues early, analyzing and proactively finding solutions
  • Demonstrated leadership of others in the delivery of complex deliverables
  • Highly efficient project management skills
  • Able to work effectively with people at all levels in an organization and quickly establish credibility
  • Have strong personal impact and ability to influence and persuade a range of stakeholders
  • An effective communicator verbally and written, in English, and in the local office language
Responsibilities
  • Lead R&D projects as the operational face of a Veeva R&D Consulting team, with responsibility for planning, organizing, and managing all aspects of delivery including scope, quality, resources, risks, and timelines
  • Be responsible for the end-to-end design, build, and delivery of deliverables that meet overall project goals and objectives
  • Identify and proactively solve problems faced by the client
  • Be a trusted client contact for strategic and operational questions, developing the relationship through face-to-face discussions, workshops, phone, and email contact
  • Manage the work and priorities of team members on your project(s)
  • Support and mentor Consultants and Associates in developing skills and professional capabilities
  • Bring to clients an excellent level of industry, market, and functional insight including R&D specific challenges
  • Proactively lead business development opportunities and proposals related to the R&D value chain
  • Develop and disseminate thought leadership and campaigns that differentiate Veeva R&D Consulting in the market for Regulatory Affairs, Clinical Strategy & Operations as well as Quality and Safety
Desired Qualifications
  • Post-graduate-level qualification, Ph.D., MD, and/or MBA
  • Network in Top 20 Life Science companies
  • Experience with digital technologies – platforms, channels, analytics tools, apps, emerging technology
  • Experience working with SaaS solutions
  • Fluency in additional European languages

Veeva Systems offers software solutions for quality, regulatory, and advertising claims management, focusing on consumer products and chemical companies. Their cloud-based platform provides visibility and traceability throughout the product journey, ensuring compliance with regulations and accelerating time-to-market. Unlike competitors, Veeva has expanded from the Life Sciences sector to address similar challenges in the Chemical and Consumer Goods markets. The company's goal is to modernize the product journey for clients while maintaining a subscription-based model for steady revenue.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Pleasanton, California

Founded

2007

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased AI-driven analytics adoption enhances data accuracy and reduces time-to-market.
  • Decentralized clinical trials demand cloud solutions, aligning with Veeva's infrastructure.
  • Growing regulatory scrutiny boosts demand for Veeva's compliance management software.

What critics are saying

  • Emerging cloud-based software providers threaten Veeva's market share.
  • Rapid technological advancements may increase Veeva's R&D costs.
  • Economic downturns could reduce client spending and affect revenue growth.

What makes Veeva Systems unique

  • Veeva Systems specializes in cloud-based software for the life sciences industry.
  • The company offers end-to-end visibility and traceability in product journeys.
  • Veeva's subscription model ensures continuous updates and improvements for clients.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Parental leave

PTO

Free food

Health, dental, & vision insurance

Gym membership reimbursement

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

0%
PR Newswire
Mar 19th, 2025
Indero Marks 40Th Study Live With Veeva Rtsm

Specialized CRO standardizes on Veeva RTSM to drive operational efficiency and faster study timelinesBARCELONA, Spain, March 19, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Indero, formerly Innovaderm Research, successfully launched its 40th RTSM study on Veeva RTSM. By standardizing with Veeva RTSM, Indero has strengthened its clinical trial operations, harnessing advanced RTSM capabilities and expert support to drive efficiency, enhance process consistency, and streamline execution."As we continue to optimize our clinical trial operations, Veeva RTSM has driven more efficient processes and closer collaboration to ensure seamless execution," said Eric Hardy, senior director, biometrics at Indero. "Because of this added speed and effectiveness, we can help bring therapies to market faster, allowing our sponsors, sites, and patients to benefit sooner."The launch of Indero's 40th RTSM study highlights the continued collaboration between the two organizations. Since first adopting Veeva RTSM, Indero has worked closely with Veeva to continuously refine and implement standardized processes that drive long-term success for its clinical trials."With its enterprise standard RTSM approach, Indero is achieving greater long-term efficiency and reliability in their studies," said Steve Simmerman, general manager, Veeva RTSM. "Partnering with Indero to standardize clinical processes will further accelerate study timelines, demonstrating a streamlined approach that can advance the industry."Additional InformationTo learn more about Veeva's enterprise standard RTSM, visit www.veeva.com/rtsm.About Veeva SystemsVeeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs

Stock Titan
Mar 19th, 2025
Indero Marks 40th Study Live with Veeva RTSM

Since first adopting Veeva RTSM, Indero has worked closely with Veeva to continuously refine and implement standardized processes that drive long-term success for its clinical trials.

Simply Wall St
Mar 13th, 2025
Veeva Systems (NYSE:VEEV) Announces Tina Hunt's Retirement From Board Before 2025 Shareholders Meeting

Veeva Systems (NYSE:VEEV) announces Tina Hunt's retirement from board before 2025 shareholders meeting.

Investing.com
Mar 12th, 2025
Veeva Systems announces board member retirement

Ms. Hunt, who has served as a director on Veeva's board, will not stand for re-election at the upcoming 2025 Annual Meeting.

PR Newswire
Mar 11th, 2025
Boehringer Ingelheim Partners With Veeva To Launch 'One Medicine Platform'

Top 20 biopharma goes live with Veeva Development Cloud to speed the delivery of treatments for currently incurable diseasesINGELHEIM, Germany and BARCELONA, Spain, March 11, 2025 /PRNewswire/ -- Today, Boehringer Ingelheim and Veeva Systems (NYSE: VEEV) have announced the launch of Boehringer's One Medicine Platform, powered by the successful implementation of Veeva Development Cloud. They first announced the One Medicine collaboration in March 2022. The unified platform brings together data and processes across clinical, regulatory, and quality, enabling Boehringer to streamline its product development. With the One Medicine Platform, Boehringer can seamlessly connect data across functions, optimize trial efficiency and collaboration with research sites, and accelerate the delivery of new medicines to treat currently incurable diseases."Together with Veeva, Boehringer has advanced its approach to clinical trials and is fulfilling our pledge to accelerate the delivery of innovative, life-transforming treatments to patients across the world," said Oliver Fink, head of learning, process and digitalization at Boehringer Ingelheim. "Veeva Development Cloud provides the technology foundation for Boehringer's One Medicine Platform, giving our teams the flexibility to design and run studies with greater speed, efficiency, and compliance.""By connecting clinical, regulatory, and quality on Veeva Development Cloud, Boehringer unifies data and breaks down silos across teams to accelerate drug development and approvals," said Rik van Mol, senior vice president, Veeva Development Cloud. "This is an exciting milestone toward realizing Veeva and Boehringer's shared mission to advance the use of data and technology to modernize clinical trials and deliver better patient outcomes."Veeva Development Cloud is the technology foundation for product development, bringing together clinical, quality, regulatory, and safety applications to simplify end-to-end business processes and deliver process excellence.Additional InformationFor more on Veeva Development Cloud, visit: veeva.com/DevelopmentCloudAbout Boehringer IngelheimBoehringer Ingelheim is a biopharmaceutical company active in both human and animal health